#Sweden #Gothenburg #EBITDA Growth #Zinzino AB #financial report

Zinzino AB's Third Quarter 2025 Report: A Leap in Growth

Zinzino AB, a prominent player in the health and wellness market, has released its interim report for the third quarter of 2025, unveiling remarkable growth figures that underscore its escalating position in the industry. The report indicates that the company's revenue for Q3 2025 reached a staggering SEK 784.1 million, which reflects a 47% increase compared to the same period last year when revenue was SEK 532.8 million. This sharp growth rate not only surpasses the previous year's performance but also demonstrates Zinzino's sustained momentum and robust market presence.

In terms of performance metrics, Zinzino reported a significant uptick in EBITDA, which reached SEK 109.7 million, up from SEK 63.0 million in Q3 2024. This resulted in an EBITDA margin increase to 14.0%, up from 11.8%. This improved margin is attributed to a stronger gross profit and enhanced synergies from acquisitions, particularly with the integration of Zurvita.

The breakdown of figures further illustrates Zinzino's expanding profitability. The gross profit for Q3 stood at SEK 277.2 million, which corresponds to a gross profit margin of 35.4%, slightly up from 33.6% in the previous year. Moreover, the net profit soared to SEK 89.4 million, starkly contrasting with the SEK 42.6 million in net profit from Q3 2024. The rise in net earnings has translated to SEK 2.47 per share, a commendable increase from SEK 1.24.

Such strong financial outcomes are further complemented by impressive cash flow from operating activities, which amounted to SEK 136.6 million compared to SEK 36.9 million in the same quarter last year. The company also reported cash and cash equivalents of SEK 529.2 million on the balance sheet, reflecting a significant increase from SEK 321.2 million.

Strategic Acquisitions: A Key to Growth

In a strategic move to bolster its market reach, during Q3 Zinzino also acquired several assets from US-based direct sales companies, Bodē Pro and Truvy. This acquisition is expected to enhance distribution capabilities across North America, Latin America, South Korea, and Japan, marking a pivotal expansion in Zinzino's global footprint.

Additionally, Zinzino's endeavors do not end here; the company announced the acquisition of Sanki aimed at further enhancing their distribution power in both North and South America. They also obtained a 35% stake in Xion International Group, affirming their commitment to expanding their own-production capacities for omega-3 oil and spirulina.

Taking Stock: Year-to-Date Performance

Analyzing the year so far, Zinzino’s total revenue for the first nine months of 2025 reached SEK 2,302.2 million, marking a 54% increase over the SEK 1,494.3 million reported for the same period in 2024. The gross profit for this year-to-date spans SEK 748.7 million, with a gross profit margin slight down to 32.5% during the same time frame. Meanwhile, the EBITDA figure stands at SEK 268.2 million, showcasing an adequate financial trajectory with an EBITDA margin of 11.6%. Net profit for the first three quarters also reveals a healthy growth, reaching SEK 200.9 million compared to SEK 126.1 million in 2024.

The strategic initiatives, product innovations, and strong sales growth position Zinzino AB as a company poised for future success.

Conclusion

The quarterly report from Zinzino AB for Q3 2025 provides valuable insight into its upward financial trajectory, driven by robust sales, strategic acquisitions, and improved profit margins. Zinzino’s ability to swiftly adapt and expand in competitive markets is commendable, reflecting not just a good performance but a promising outlook for the future. As the company continues to innovate and grow, stakeholders and investors will be keenly observing its next steps in the ever-evolving global health and wellness landscape.